• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

45-49 岁或 50-54 岁行结肠镜检查后结直肠癌的发病率。

Colorectal Cancer Incidence After Colonoscopy at Ages 45-49 or 50-54 Years.

机构信息

University of California, Los Angeles, California.

Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California.

出版信息

Gastroenterology. 2021 May;160(6):2018-2028.e13. doi: 10.1053/j.gastro.2021.02.015. Epub 2021 Feb 9.

DOI:10.1053/j.gastro.2021.02.015
PMID:33577872
Abstract

BACKGROUND & AIMS: Colorectal cancer (CRC) incidence at ages younger than 50 years is increasing, leading to proposals to lower the CRC screening initiation age to 45 years. Data on the effectiveness of CRC screening at ages 45-49 years are lacking.

METHODS

We studied the association between undergoing colonoscopy at ages 45-49 or 50-54 years and CRC incidence in a retrospective population-based cohort study using Florida's linked Healthcare Cost and Utilization Project databases with mandated reporting from 2005 to 2017 and Cox models extended for time-varying exposure.

RESULTS

Among 195,600 persons with and 2.6 million without exposure to colonoscopy at ages 45-49 years, 276 and 4844 developed CRC, resulting in CRC incidence rates of 20.8 (95% CI, 18.5-23.4) and 30.6 (95% CI, 29.8-31.5) per 100,000 person-years, respectively. Among 660,248 persons with and 2.4 million without exposure to colonoscopy at ages 50-54 years, 798 and 6757 developed CRC, resulting in CRC incidence rates of 19.0 (95% CI, 17.7-20.4) and 51.9 (95% CI, 50.7-53.1) per 100,000 person-years, respectively. The adjusted hazard ratios for incident CRC after undergoing compared with not undergoing colonoscopy were 0.50 (95% CI, 0.44-0.56) at ages 45-49 years and 0.32 (95% CI, 0.29-0.34) at ages 50-54 years. The results were similar for women and men (hazard ratio, 0.48; 95% CI, 0.40-0.57 and hazard ratio, 0.52; 95% CI, 0.43-0.62 at ages 45-49 years, and hazard ratio, 0.35; 95% CI, 0.31-0.39 and hazard ratio, 0.29; 95% CI, 0.26-0.32 at ages 50-54 years, respectively).

CONCLUSIONS

Colonoscopy at ages 45-49 or 50-54 years was associated with substantial decreases in subsequent CRC incidence. These findings can inform screening guidelines.

摘要

背景与目的

50 岁以下人群的结直肠癌(CRC)发病率正在上升,这导致有人提议将 CRC 筛查起始年龄降低至 45 岁。45-49 岁人群进行 CRC 筛查的有效性数据尚缺乏。

方法

我们使用佛罗里达州的强制性报告的 Healthcare Cost and Utilization Project 数据库进行了一项回顾性基于人群的队列研究,使用 Cox 模型对 2005 年至 2017 年的数据进行了时间变化暴露的扩展,研究了 45-49 岁或 50-54 岁行结肠镜检查与 CRC 发病之间的相关性。

结果

在 195600 名接受和 260 万名未接受 45-49 岁结肠镜检查的人群中,分别有 276 人和 4844 人发生 CRC,导致 CRC 发病率分别为每 100000 人年 20.8(95%CI,18.5-23.4)和 30.6(95%CI,29.8-31.5)。在 660248 名接受和 240 万名未接受 50-54 岁结肠镜检查的人群中,分别有 798 人和 6757 人发生 CRC,导致 CRC 发病率分别为每 100000 人年 19.0(95%CI,17.7-20.4)和 51.9(95%CI,50.7-53.1)。与未行结肠镜检查相比,行结肠镜检查后 CRC 的调整后的发病风险比分别为 45-49 岁时 0.50(95%CI,0.44-0.56)和 50-54 岁时 0.32(95%CI,0.29-0.34)。女性和男性的结果相似(45-49 岁时,风险比为 0.48;95%CI,0.40-0.57,风险比为 0.52;95%CI,0.43-0.62,50-54 岁时,风险比为 0.35;95%CI,0.31-0.39,风险比为 0.29;95%CI,0.26-0.32)。

结论

45-49 岁或 50-54 岁行结肠镜检查与随后 CRC 发病率的显著下降相关。这些发现可以为筛查指南提供信息。

相似文献

1
Colorectal Cancer Incidence After Colonoscopy at Ages 45-49 or 50-54 Years.45-49 岁或 50-54 岁行结肠镜检查后结直肠癌的发病率。
Gastroenterology. 2021 May;160(6):2018-2028.e13. doi: 10.1053/j.gastro.2021.02.015. Epub 2021 Feb 9.
2
Optimal Stopping Ages for Colorectal Cancer Screening.结直肠癌筛查的最佳停止年龄。
JAMA Netw Open. 2024 Dec 2;7(12):e2451715. doi: 10.1001/jamanetworkopen.2024.51715.
3
Interval Colorectal Cancers in a Fecal Immunochemical Test-Based Screening Program.基于粪便免疫化学检测的筛查项目中的间隔期结直肠癌
JAMA Netw Open. 2025 Jul 1;8(7):e2523441. doi: 10.1001/jamanetworkopen.2025.23441.
4
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.基于愈创木脂的粪便潜血试验与粪便免疫化学试验用于一般风险人群结直肠癌筛查。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
5
Duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy in Ontario, Canada: a population-based cohort study.加拿大安大略省全结肠镜检查后结直肠癌发病率和死亡率降低风险的持续时间:一项基于人群的队列研究。
Lancet Gastroenterol Hepatol. 2024 Jul;9(7):601-608. doi: 10.1016/S2468-1253(24)00084-0. Epub 2024 May 16.
6
Stress-Testing US Colorectal Cancer Screening Guidelines: Decennial Colonoscopy from Age 45 is Robust to Natural History Uncertainty and Colonoscopy Sensitivity Assumptions.对美国结直肠癌筛查指南进行压力测试:从45岁开始每十年进行一次结肠镜检查对自然病史的不确定性和结肠镜检查敏感性假设具有稳健性。
Med Decis Making. 2025 Jul;45(5):557-568. doi: 10.1177/0272989X251334373. Epub 2025 Apr 29.
7
Long-Term Effectiveness Associated With Fecal Immunochemical Testing for Early-Age Screening.粪便免疫化学检测用于早期筛查的长期有效性
JAMA Oncol. 2025 Jun 12. doi: 10.1001/jamaoncol.2025.1433.
8
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Fecal immunochemical test surveillance in colorectal cancer following adenoma resection: A longitudinal, population-based linked cohort study in China.腺瘤切除术后结直肠癌的粪便免疫化学检测监测:中国一项基于人群的纵向队列关联研究。
PLoS Med. 2025 Sep 2;22(9):e1004687. doi: 10.1371/journal.pmed.1004687. eCollection 2025 Sep.

引用本文的文献

1
Early Detection and Age-Comparative Analysis of Colorectal Cancer Screening: Insights from the Turkish Population.结直肠癌筛查的早期检测及年龄比较分析:来自土耳其人群的见解
Curr Oncol. 2025 Mar 6;32(3):153. doi: 10.3390/curroncol32030153.
2
Morphological and functional analysis of colorectal cancer cell lines in 2D and 3D culture models.二维和三维培养模型中结肠癌细胞系的形态学和功能分析
Sci Rep. 2025 Jan 24;15(1):3047. doi: 10.1038/s41598-025-87660-x.
3
Colorectal Cancer and Precursor Lesion Prevalence in Adults Younger Than 50 Years Without Symptoms.

本文引用的文献

1
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
2
Screening colonoscopy and flexible sigmoidoscopy for reduction of colorectal cancer incidence: A case-control study.筛查结肠镜检查和乙状结肠镜检查对降低结直肠癌发病率的作用:一项病例对照研究。
PLoS One. 2019 Dec 5;14(12):e0226027. doi: 10.1371/journal.pone.0226027. eCollection 2019.
3
Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis.
50 岁以下无症状成年人的结直肠癌及癌前病变患病率。
JAMA Netw Open. 2023 Dec 1;6(12):e2334757. doi: 10.1001/jamanetworkopen.2023.34757.
4
Comparison of robotic-assisted versus conventional laparoscopic surgery in colorectal cancer resection: a systemic review and meta-analysis of randomized controlled trials.机器人辅助手术与传统腹腔镜手术在结直肠癌切除术中的比较:一项随机对照试验的系统评价和荟萃分析
Front Oncol. 2023 Oct 26;13:1273378. doi: 10.3389/fonc.2023.1273378. eCollection 2023.
5
CT Colonography and Colorectal Carcinoma: Current Trends and Emerging Developments.CT结肠成像与结直肠癌:当前趋势与新进展
Cureus. 2022 May 11;14(5):e24916. doi: 10.7759/cureus.24916. eCollection 2022 May.
6
Disparate age and sex distribution of sessile serrated lesions and conventional adenomas in an outpatient colonoscopy population-implications for colorectal cancer screening?门诊结肠镜检查人群中无蒂锯齿状病变和传统腺瘤的年龄和性别分布差异——对结直肠癌筛查的影响?
Int J Colorectal Dis. 2022 Jul;37(7):1569-1579. doi: 10.1007/s00384-022-04191-x. Epub 2022 Jun 4.
7
Factors associated with colorectal cancer screening intent and uptake among adult Non-Hispanic Black men.成年非西班牙裔黑人男性中与结直肠癌筛查意愿及接受情况相关的因素。
Am J Cancer Res. 2021 Dec 15;11(12):6200-6213. eCollection 2021.
8
Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset.ColoCare研究中结直肠癌的临床特征与结局:按发病年龄的差异
Cancers (Basel). 2021 Jul 29;13(15):3817. doi: 10.3390/cancers13153817.
9
Oxymatrine Synergistically Enhances Doxorubicin Anticancer Effects in Colorectal Cancer.氧化苦参碱协同增强阿霉素对结直肠癌的抗癌作用。
Front Pharmacol. 2021 Jun 30;12:673432. doi: 10.3389/fphar.2021.673432. eCollection 2021.
粪便检测、乙状结肠镜检查或结肠镜检查用于结直肠癌筛查:一项系统评价和网状Meta分析。
BMJ Open. 2019 Oct 2;9(10):e032773. doi: 10.1136/bmjopen-2019-032773.
4
Global patterns and trends in colorectal cancer incidence in young adults.全球年轻人结直肠癌发病率的模式和趋势。
Gut. 2019 Dec;68(12):2179-2185. doi: 10.1136/gutjnl-2019-319511. Epub 2019 Sep 5.
5
All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: A review and modeling study.全因死亡率与癌症特异性死亡率作为癌症筛查试验的结局:一项综述和建模研究。
Cancer Med. 2019 Oct;8(13):6127-6138. doi: 10.1002/cam4.2476. Epub 2019 Aug 18.
6
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.6350 名致病性错配修复变异携带者的基因、年龄和性别与癌症风险:来自前瞻性 Lynch 综合征数据库的研究结果。
Genet Med. 2020 Jan;22(1):15-25. doi: 10.1038/s41436-019-0596-9. Epub 2019 Jul 24.
7
Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.45 岁而非 50 岁开始对一般风险人群进行结直肠癌筛查的成本效益和国家影响。
Gastroenterology. 2019 Jul;157(1):137-148. doi: 10.1053/j.gastro.2019.03.023. Epub 2019 Mar 28.
8
Case-Control Studies of the Efficacy of Screening Tests That Seek to Prevent Cancer Incidence: Results of an Approach That Utilizes Administrative Claims Data That Do Not Provide Information Regarding Test Indication.旨在预防癌症发病率的筛检试验的功效之病例对照研究:利用不提供有关试验适应证信息的行政索赔数据的方法的结果。
Am J Epidemiol. 2019 Apr 1;188(4):703-708. doi: 10.1093/aje/kwy274.
9
Validation of Administrative Big Database for Colorectal Cancer Searched by International Classification of Disease 10th Codes in Korean: A Retrospective Big-cohort Study.韩国使用国际疾病分类第10版编码检索的结直肠癌管理大数据库的验证:一项回顾性大队列研究
J Cancer Prev. 2018 Dec;23(4):183-190. doi: 10.15430/JCP.2018.23.4.183. Epub 2018 Dec 30.
10
Observational Studies That Seek to Emulate a Randomized Trial of Screening to Reduce the Incidence of Cancer: Do They Address the Question to Which We'd Like to Have an Answer?旨在模拟随机试验以筛查降低癌症发病率的观察性研究:它们是否回答了我们希望得到答案的问题?
Am J Epidemiol. 2019 Oct 1;188(10):1761-1763. doi: 10.1093/aje/kwy286.